JP2022529500A5 - - Google Patents

Info

Publication number
JP2022529500A5
JP2022529500A5 JP2021562980A JP2021562980A JP2022529500A5 JP 2022529500 A5 JP2022529500 A5 JP 2022529500A5 JP 2021562980 A JP2021562980 A JP 2021562980A JP 2021562980 A JP2021562980 A JP 2021562980A JP 2022529500 A5 JP2022529500 A5 JP 2022529500A5
Authority
JP
Japan
Prior art keywords
fusion protein
nucleic acid
seq
acid construct
recombinant virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562980A
Other languages
English (en)
Japanese (ja)
Other versions
JP7618581B2 (ja
JP2022529500A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029590 external-priority patent/WO2020219726A1/en
Publication of JP2022529500A publication Critical patent/JP2022529500A/ja
Publication of JP2022529500A5 publication Critical patent/JP2022529500A5/ja
Priority to JP2025002919A priority Critical patent/JP2025069161A/ja
Application granted granted Critical
Publication of JP7618581B2 publication Critical patent/JP7618581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021562980A 2019-04-23 2020-04-23 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用 Active JP7618581B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025002919A JP2025069161A (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962837523P 2019-04-23 2019-04-23
US62/837,523 2019-04-23
US202062964844P 2020-01-23 2020-01-23
US62/964,844 2020-01-23
PCT/US2020/029590 WO2020219726A1 (en) 2019-04-23 2020-04-23 Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025002919A Division JP2025069161A (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Publications (3)

Publication Number Publication Date
JP2022529500A JP2022529500A (ja) 2022-06-22
JP2022529500A5 true JP2022529500A5 (enExample) 2023-04-28
JP7618581B2 JP7618581B2 (ja) 2025-01-21

Family

ID=70680681

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021562980A Active JP7618581B2 (ja) 2019-04-23 2020-04-23 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用
JP2025002919A Pending JP2025069161A (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025002919A Pending JP2025069161A (ja) 2019-04-23 2025-01-08 9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用

Country Status (16)

Country Link
US (3) US12139517B2 (enExample)
EP (1) EP3958871A1 (enExample)
JP (2) JP7618581B2 (enExample)
KR (1) KR20220003561A (enExample)
CN (2) CN120960394A (enExample)
AU (1) AU2020262281B2 (enExample)
BR (1) BR112021020868A2 (enExample)
CA (1) CA3137368A1 (enExample)
CO (1) CO2021015653A2 (enExample)
IL (1) IL287384A (enExample)
MX (1) MX2021012836A (enExample)
PE (1) PE20212332A1 (enExample)
PH (1) PH12021552554A1 (enExample)
SG (1) SG11202111443SA (enExample)
TW (2) TW202521561A (enExample)
WO (1) WO2020219726A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102925054B1 (ko) 2018-12-20 2026-02-10 리제너론 파마슈티칼스 인코포레이티드 뉴클레아제-매개 반복부 팽창
TW202521561A (zh) * 2019-04-23 2025-06-01 美商聖加莫治療股份有限公司 染色體9開放讀框72基因表現之調節子及其用途
GB202010075D0 (en) * 2020-07-01 2020-08-12 Imp College Innovations Ltd Therapeutic nucleic acids, peptides and uses
GB2625500B (en) 2021-09-21 2026-04-01 Scribe Therapeutics Inc Engineered CasX repressor systems

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420032A (en) 1991-12-23 1995-05-30 Universitge Laval Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
US5792632A (en) 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
DE69534629D1 (de) 1994-01-18 2005-12-29 Scripps Research Inst Derivate von zinkfingerproteinen und methoden
JP4285766B2 (ja) 1994-03-23 2009-06-24 オハイオ ユニバーシティ 緻密にした核酸および細胞へのデリバリ
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
USRE39229E1 (en) 1994-08-20 2006-08-08 Gendaq Limited Binding proteins for recognition of DNA
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
ES2341926T3 (es) 1998-03-02 2010-06-29 Massachusetts Institute Of Technology Poliproteinas con dedos de cinc que tienen enlazadores mejorados.
WO1999061066A2 (en) 1998-05-27 1999-12-02 Avigen, Inc. Convection-enhanced delivery of aav vectors
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
AU7866400A (en) 1999-10-07 2001-05-10 Baylor College Of Medicine Novel zinc finger protein
AU776576B2 (en) 1999-12-06 2004-09-16 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6689558B2 (en) 2000-02-08 2004-02-10 Sangamo Biosciences, Inc. Cells for drug discovery
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
WO2002026959A2 (en) 2000-09-28 2002-04-04 Sangamo Biosciences, Inc. Nuclear reprogramming using iwsi and related chromatin remodeling atpases
US20050235369A1 (en) * 2001-03-28 2005-10-20 Yen Choo Gene regulation II
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
US7182944B2 (en) 2001-04-25 2007-02-27 The United States Of America As Represented By The Department Of Health And Human Services Methods of increasing distribution of nucleic acids
JP2005500061A (ja) 2001-08-20 2005-01-06 ザ スクリップス リサーチ インスティテュート Cnnについての亜鉛フィンガー結合ドメイン
DK2573170T3 (en) 2001-12-17 2018-04-09 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 9, vectors containing them, and their use
US7074596B2 (en) 2002-03-25 2006-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse mRNA cap analogues
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
CN1897977A (zh) 2003-10-20 2007-01-17 Ns基因公司 帕金森氏病的体内基因治疗
MX2007003850A (es) 2004-10-05 2007-11-21 Genzyme Corp Canula escalonada.
CA2607104A1 (en) 2005-05-05 2006-11-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences
EP1928557B1 (en) 2005-08-23 2018-06-06 The Regents of The University of California Reflux resistant cannula and system for chronic delivery of therapeutic agents using convection-enhanced delivery
ES2582091T3 (es) 2005-10-18 2016-09-09 Precision Biosciences Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
DK2019683T4 (da) 2006-04-25 2022-08-29 Univ California Indgivelse af vækstfaktorer til behandling af CNS-lidelser
EP2027262B1 (en) 2006-05-25 2010-03-31 Sangamo Biosciences Inc. Variant foki cleavage half-domains
US7837668B2 (en) 2006-10-10 2010-11-23 Ceregene, Inc. Needle assembly for use in delivering precise dosages of proteinaceous pharmaceutical compositions and methods for use of same
CN104072561B (zh) 2007-06-19 2017-12-22 路易斯安那州州立大学及农业机械学院管理委员会 信使rna帽的抗‑反向硫代磷酸类似物的合成和用途
EP2188384B1 (en) 2007-09-27 2015-07-15 Sangamo BioSciences, Inc. Rapid in vivo identification of biologically active nucleases
EP2250184A4 (en) 2008-02-08 2011-05-04 Sangamo Biosciences Inc TREATMENT OF CHRONIC PAIN WITH ZINC FINGER PROTEINS
WO2009151591A2 (en) 2008-06-10 2009-12-17 Sangamo Biosciences, Inc. Methods and compositions for generation of bax- and bak-deficient cell lines
SG191561A1 (en) 2008-08-22 2013-07-31 Sangamo Biosciences Inc Methods and compositions for targeted single-stranded cleavage and targeted integration
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
CA2769262C (en) 2009-07-28 2019-04-30 Sangamo Biosciences, Inc. Methods and compositions for treating trinucleotide repeat disorders
CA2769670C (en) 2009-07-31 2018-10-02 Ethris Gmbh Rna with a combination of unmodified and modified nucleotides for protein expression
US8586526B2 (en) 2010-05-17 2013-11-19 Sangamo Biosciences, Inc. DNA-binding proteins and uses thereof
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
ES2751916T3 (es) 2010-02-08 2020-04-02 Sangamo Therapeutics Inc Semidominios de escisión genomanipulados
HRP20200254T1 (hr) 2010-05-03 2020-05-29 Sangamo Therapeutics, Inc. Pripravci za povezivanje modula cink fingera
HK1200871A1 (en) 2011-11-16 2015-08-14 Sangamo Therapeutics, Inc. Modified dna-binding proteins and uses thereof
WO2013130824A1 (en) * 2012-02-29 2013-09-06 Sangamo Biosciences, Inc. Methods and compositions for treating huntington's disease
AU2014223344A1 (en) 2013-02-27 2015-10-01 Massachusetts Institute Of Technology T cell balance gene expression, compositions of matters and methods of use thereof
CN105683376A (zh) 2013-05-15 2016-06-15 桑格摩生物科学股份有限公司 用于治疗遗传病状的方法和组合物
ES2739288T3 (es) 2013-09-13 2020-01-30 California Inst Of Techn Recuperación selectiva
WO2015070212A1 (en) 2013-11-11 2015-05-14 Sangamo Biosciences, Inc. Methods and compositions for treating huntington's disease
JP6712948B2 (ja) 2013-12-12 2020-06-24 ザ・ブロード・インスティテュート・インコーポレイテッド 組成物、及びヌクレオチドリピート障害におけるcrispr−cas系の使用方法
CN106459894B (zh) 2014-03-18 2020-02-18 桑格摩生物科学股份有限公司 用于调控锌指蛋白表达的方法和组合物
WO2015153760A2 (en) 2014-04-01 2015-10-08 Sangamo Biosciences, Inc. Methods and compositions for prevention or treatment of a nervous system disorder
WO2015171932A1 (en) 2014-05-08 2015-11-12 Sangamo Biosciences, Inc. Methods and compositions for treating huntington's disease
WO2015188056A1 (en) * 2014-06-05 2015-12-10 Sangamo Biosciences, Inc. Methods and compositions for nuclease design
GB201418965D0 (enExample) 2014-10-24 2014-12-10 Ospedale San Raffaele And Fond Telethon
US11390908B2 (en) 2015-09-02 2022-07-19 University Of Massachusetts Detection of gene loci with CRISPR arrayed repeats and/or polychromatic single guide ribonucleic acids
CA3005968A1 (en) 2015-11-23 2017-06-01 The Regents Of The University Of California Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9
KR20180118111A (ko) * 2015-12-23 2018-10-30 크리스퍼 테라퓨틱스 아게 근위축성 측색 경화증 및/또는 전두측두엽 퇴행의 치료 물질 및 방법
US11174469B2 (en) * 2016-06-29 2021-11-16 Crispr Therapeutics Ag Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders
AU2017312132A1 (en) 2016-08-19 2019-03-21 Bluebird Bio, Inc. Genome editing enhancers
KR102455249B1 (ko) 2016-08-24 2022-10-17 상가모 테라퓨틱스, 인코포레이티드 가공된 표적 특이적 뉴클레아제
WO2018039471A2 (en) 2016-08-25 2018-03-01 Trustees Of Boston University Synthetic transcriptional and epigenetic regulators based on engineered, orthogonal zinc finger proteins
IL266862B2 (en) 2016-12-01 2024-01-01 Sangamo Therapeutics Inc Tau modulators and methods and preparations for their administration
US11859179B2 (en) * 2017-05-09 2024-01-02 University Of Massachusetts Methods of treating amyotrophic lateral sclerosis (ALS)
WO2019084140A1 (en) * 2017-10-24 2019-05-02 Sangamo Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES
TW202521561A (zh) * 2019-04-23 2025-06-01 美商聖加莫治療股份有限公司 染色體9開放讀框72基因表現之調節子及其用途

Similar Documents

Publication Publication Date Title
JP2022529500A5 (enExample)
CN106459932B (zh) 高胆红素血症的治疗
CA2985372C (en) Polynucleotides, vectors and methods for insertion and expression of transgenes
JP7616995B2 (ja) 神経変性疾患のための遺伝子治療
CN120324641A (zh) 用于治疗达农病的基因治疗载体
CN113710693B (zh) Dna结合结构域反式激活因子及其用途
JP2022507402A (ja) 肝特異的ウイルスプロモーター及びその使用方法
CN104936606A (zh) 糖原贮积病的基因疗法
CA2369985A1 (en) Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
WO2020039425A1 (en) Vectors expressing klotho for treating cancer
JP2022521432A5 (enExample)
CA2859920A1 (en) Variants of yeast ndi1 gene, and uses thereof in the treatment of disease associated with mitochondrial dysfunction
EP4185303A1 (en) Dna-binding domain transactivators and uses thereof
TW202426033A (zh) Bag3用於治療心臟澱粉樣變性之方法及用途
EP4518882A1 (en) Bag3 and protein quality control in the brain
CN117916365B (zh) 用于治疗结晶样视网膜变性的重组腺相关病毒载体
KR20230112672A (ko) 신경변성 질환을 위한 유전자 요법
JP2023542241A5 (enExample)
RU2021133872A (ru) Модуляторы экспрессии гена открытой рамки считывания 72 хромосомы 9 и их применения
CN115996758A (zh) 使sgcg在肌肉和心脏中充分表达的基因治疗表达系统
CA3218631A1 (en) Vector system
JP2023549620A (ja) 組換え補体タンパク質を産生させる方法、そのベクターおよび治療的使用
RU2024129746A (ru) Модуляторы экспрессии гена открытой рамки считывания 72 хромосомы 9 и их применения
JP2023545972A (ja) アルファ-シヌクレイン発現を抑制するための新規ジンクフィンガータンパク質転写因子
KR20200051679A (ko) 신경병증성 통증의 치료를 위한 방법 및 조성물